OpenAI introduced GPT‑Rosalind, a frontier reasoning model aimed at speeding drug discovery, genomics, protein reasoning, and scientific workflows.
2 results for: genomics
OpenAI Debuts GPT-Rosalind for Drug Discovery and Genomics
OpenAI launched GPT-Rosalind, its first life‑sciences model aimed at accelerating drug discovery and genomic analysis and cutting long development timelines.